BillionToOne, Inc. - 10-Q Filing
BillionToOne, Inc. reports Q3 2026 financial results including segment data for Prenatal, Oncology, and Clinical Trial Support.
Tickers: $BLLN
BillionToOne, Inc. reports Q3 2026 financial results including segment data for Prenatal, Oncology, and Clinical Trial Support.
Tickers: $BLLN